|
| | 10300HB2189sam001 | - 2 - | LRB103 24836 BMS 61259 a |
|
|
1 | | insulin drug that is
administered to a patient intravenously. |
2 | | (b) This Section applies to a group or individual policy |
3 | | of accident and health insurance amended, delivered, issued, |
4 | | or renewed on or after the effective date of this amendatory |
5 | | Act of the 101st General Assembly. |
6 | | (c) An insurer that provides coverage for prescription |
7 | | insulin drugs pursuant to the terms of a health coverage plan |
8 | | the insurer offers shall limit the total amount that an |
9 | | insured is required to pay for a 30-day supply of covered |
10 | | prescription insulin drugs at an amount not to exceed $35 |
11 | | $100 , regardless of the quantity or type of covered |
12 | | prescription insulin drug used to fill the insured's |
13 | | prescription. |
14 | | (d) Nothing in this Section prevents an insurer from |
15 | | reducing an insured's cost sharing by an amount greater than |
16 | | the amount specified in subsection (c). |
17 | | (e) The Director may use any of the Director's enforcement |
18 | | powers to obtain an insurer's compliance with this Section. |
19 | | (f) The Department may adopt rules as necessary to |
20 | | implement and administer this Section and to align it with |
21 | | federal requirements. |
22 | | (g) On January 1 of each year, the limit on the amount that |
23 | | an insured is required to pay for a 30-day supply of a covered |
24 | | prescription insulin drug shall increase by a percentage equal |
25 | | to the percentage change from the preceding year in the |
26 | | medical care component of the Consumer Price Index of the |